Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

NCT ID: NCT03891394

Last Updated: 2019-03-28

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 110 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2019-04-01
• Study Completion Date: 2019-10-30

Brief Summary

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

Conditions

Preeclampsia

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Interventions

Human epididymis protein 4

Human epididymis protein 4 serum level in predicting persistent proteniuria

Intervention Type: DIAGNOSTIC_TEST

Eligibility Criteria

Inclusion Criteria

1. Pregnant women 18-35 years old.

2. Fulfilling the criteria for diagnosis of sever preeclampsia.

3. Fulfilling the criteria for diagnosis of HELLP syndrome

Exclusion Criteria

1. Diabetes mellitus

2. Preexisting renal disease.

3. Chronic hypertension

4. Rheumatologic diseases

5. Adnexal mass.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 35 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Ain Shams University

OTHER

Sponsor Role: lead

Responsible Party

Radwa Rasheedy Ali

principal investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

ainshamHE4

Identifier Type: -

Identifier Source: org_study_id